Tekla Capital Management’s Allergan plc AGN.PRA Stock Holding History

Tekla Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,000	Closed	-$2.93M	–	197
2017 Q4	$2.93M	Hold	5,000	–	–	0.11%	111
2017 Q3	$3.69M	Hold	5,000	–	–	0.13%	95
2017 Q2	$4.34M	Hold	5,000	–	–	0.16%	91
2017 Q1	$4.25M	Hold	5,000	–	–	0.16%	90
2016 Q4	$3.81M	Hold	5,000	–	–	0.16%	85
2016 Q3	$4.11M	Hold	5,000	–	–	0.16%	91
2016 Q2	$4.17M	Hold	5,000	–	–	0.17%	99
2016 Q1	$4.6M	Hold	5,000	–	–	0.2%	91
2015 Q4	$5.15M	Hold	5,000	–	–	0.19%	94
2015 Q3	$4.72M	Hold	5,000	–	–	0.17%	102
2015 Q2	$5.21M	Buy	+5,000	New	+$5.23M	0.19%	85

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Tekla Capital Management's AGN.PRA Position: Q1 2018 in Review

Tekla Capital Management sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 5,000 shares — an estimated $2.93M sold.

Tekla Capital Management first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $5.21M in Q2 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Tekla Capital Management reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Tekla Capital Management sold 5,000 Allergan plc shares in Q1 2018, an estimated $2.93M.
Tekla Capital Management first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
Tekla Capital Management's Allergan plc position peaked at $5.21M in Q2 2015.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Tekla Capital Management's 13F filing for Q1 2018, filed 14 May 2018.